Katarı́na Rašlová

3.7k citations

46 papers · 1.6k indexed · 1 hit paper · h-index 17

Molecular Biology
Cancer Research top 5%
Endocrinology, Diabetes and Metabolism top 5%
Surgery top 10%
Health, Toxicology and Mutagenesis top 5%

Co-authors: Mária Dušinská Andrew Collins Helena Petrovská Martina Somorovská Nicholas J. Vaughan Mihalis I. Panayiotidis Susan J. Duthie Michael Franklin
Topics: Lipoproteins and Cardiovascular Health (17 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers)Antioxidant Activity and Oxidative Stress (9 papers)
Cited by: Cancer Research Endocrinology, Diabetes and Metabolism Biochemistry
Journals: PLoS ONE Free Radical Biology and Medicine Food and Chemical Toxicology
Partner nations: Slovakia Czechia United Kingdom

In The Last Decade

Katarı́na Rašlová

45 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comet assay in human biomonitoring studies: Reliability, validation, and applications

1997 561 citations Andrew Collins, Mária Dušinská et al. Environmental and Molecular Mutagenesis profile →

Peers

Countries citing papers authored by Katarı́na Rašlová

Since Specialization

Citations

This map shows the geographic impact of Katarı́na Rašlová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarı́na Rašlová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarı́na Rašlová more than expected).

Fields of papers citing papers by Katarı́na Rašlová

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarı́na Rašlová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarı́na Rašlová. The network helps show where Katarı́na Rašlová may publish in the future.

Co-authorship network of co-authors of Katarı́na Rašlová

This figure shows the co-authorship network connecting the top 25 collaborators of Katarı́na Rašlová. A scholar is included among the top collaborators of Katarı́na Rašlová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarı́na Rašlová. Katarı́na Rašlová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO , a crossover study of basal insulin‐treated adults with type 2 diabetes and risk factors for hypoglycaemia 2021 ·Diabetes Obesity and Metabolism ·Ronald Goldenberg,Vanita R. Aroda,Liana K. Billings,(unknown),Anders Meller Donatsky,Ehsan Parvaresh Rizi,Gracjan Podgorski,Katarı́na Rašlová,David C. Klonoff,Richard M. Bergenstal	18
2	Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study 2021 ·Atherosclerosis ·Michal Vráblík,Bohumil Seifert,Alexander Parkhomenko,Maciej Banach,Jacek Jerzy Jozwiak,Róbert Gábor Kiss,Dan Gaiță,Katarı́na Rašlová,(unknown),Sarah Bray,Kausik K. Ray	42
3	The Impact of the International Cooperation On Familial Hypercholesterolemia Screening and Treatment: Results from the ScreenPro FH Project 2019 ·Current Atherosclerosis Reports ·R Češka,Gustavs Latkovskis,М. В. Ежов,Tomáš Freiberger,Katarina Lalić,Olena Mitchenko,György Paragh,Žaneta Petrulionienė,Belma Pojskić,Katarı́na Rašlová,Aleksandr B. Shek,Branislav Vohnout,(unknown),(unknown)	10
4	Therapeutic plasma exchange in secondary prevention of acute pancreatitis in pregnant patient with familial hyperchylomicronemia 2018 ·Biomedical Papers ·(unknown),(unknown),(unknown),(unknown),(unknown),Katarı́na Rašlová,Ivana Dedinská,(unknown),(unknown),Péter Galajda,Marián Mokáň	7
5	Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry 2018 ·Atherosclerosis ·Michal Vráblík,Katarı́na Rašlová,Branislav Vohnout,V. Bláha,(unknown),(unknown),(unknown),Robin Urbánek,Jana Mašková,Vladimír Soška,Tomáš Freiberger	18
6	[Diabetes and dyslipidemia: Why are they so closely related?] 2017 ·PubMed ·Katarı́na Rašlová	7
7	The Molecular Genetic Background of Familial Hypercholesterolemia: Data From the Slovak Nation-Wide Survey 2017 ·Physiological Research ·(unknown),Branislav Vohnout,Daniela Staníková,Miroslava Hučková,(unknown),(unknown),Miriam Kozárová,Ľubomíra Fábryová,(unknown),Juraj Staník,I Klimeś,Katarı́na Rašlová,Daniela Gašperíková	6
8	Genetic testing of familial hypercholesterolemia in a real clinical setting 2016 ·Wiener klinische Wochenschrift ·Branislav Vohnout,(unknown),Miroslava Hučková,I Klimeś,Daniela Gašperíková,Katarı́na Rašlová	7
9	An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog 2010 ·Vascular Health and Risk Management ·Katarı́na Rašlová	24
10	Apolipoprotein E polymorphism in relation to plasma lipid levels and other risk factors of atherosclerosis in two ethnic groups from Slovakia. 2006 ·PubMed ·Daniela Siváková,(unknown),(unknown),Katarı́na Rašlová,Ladislava Wsólová,(unknown),(unknown)	6
11	Seasonal changes in markers of oxidative damage to lipids and DNA; correlations with seasonal variation in diet 2004 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Božena Smolková,Mária Dušinská,Katarı́na Rašlová,Geraldine McNeill,Viera Spustová,P Blažı́ček,Alexandra Horská,Andrew Collins	45
12	Effect of C677T methylenetetrahydrofolate reductase gene polymorphism on plasma homocysteine levels in ethnic groups. 2004 ·Physiological Research ·(unknown),Katarı́na Rašlová,(unknown),(unknown),Ladislava Wsólová,Mária Avdičová,P Blažı́ček,J. Lietava,Daniela Siváková	12
13	DNA damage and antioxidants; fluctuations through the year in a central European population group 2002 ·Food and Chemical Toxicology ·Mária Dušinská,(unknown),Monika Ursı́nyová,(unknown),Božena Smolková,Ladislava Wsólová,Katarı́na Rašlová,Andrew Collins	51
14	Atherogenic lipoprotein profile in families with and without history of early myocardial infarction 2001 ·Physiological Research ·M Dobiášová,Katarı́na Rašlová,Hana Rauchová,Branislav Vohnout,(unknown),J. Frohlich	22
15	Risk factors for atherosclerosis in survivors of myocardial infarction and their spouses: Comparison to controls without personal and family history of atherosclerosis 2001 ·Metabolism ·Katarı́na Rašlová,Božena Smolková,Branislav Vohnout,(unknown),Jiří Fröhlich	17
16	Effect of ciprofibrate on lipoprotein metabolism and oxidative stress parameters in patients with type 2 diabetes mellitus and atherogenic lipoprotein phenotype 2000 ·Acta Diabetologica ·Katarı́na Rašlová,A Nagyová,M Dobiášová,(unknown),Mária Dušinská	10
17	Serum Lipid Resistance to Oxidation and Uric Acid Levels in Subjects with Down's s Syndrome 2000 ·Physiological Research ·A Nagyová,M Šustrová,Katarı́na Rašlová	13
18	DNA Damage in Diabetes: Correlation with a Clinical Marker 1998 ·Free Radical Biology and Medicine ·Andrew Collins,Katarı́na Rašlová,Martina Somorovská,Helena Petrovská,A Ondrusova,Branislav Vohnout,(unknown),Mária Dušinská	153
19	Apolipoprotein E genotypes in offspring with a positive and negative family history of premature myocardial infarction 1998 ·Clinical Genetics ·Katarı́na Rašlová,Božena Smolková,Branislav Vohnout,Branislav Schifferdecker,R. Poledne,Mária Dušinská	7
20	Comet assay in human biomonitoring studies: Reliability, validation, and applicationsbreakdown → 1997 ·Environmental and Molecular Mutagenesis ·Andrew Collins,Mária Dušinská,Michael Franklin,Martina Somorovská,Helena Petrovská,Susan J. Duthie,(unknown),Mihalis I. Panayiotidis,Katarı́na Rašlová,Nicholas J. Vaughan	561

About Katarı́na Rašlová

Katarı́na Rašlová is a scholar working on Biochemistry, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 46 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Antioxidant Activity and Oxidative Stress (9 papers). The work is most often cited by research in Cancer Research (423 citations), Endocrinology, Diabetes and Metabolism (389 citations) and Biochemistry (124 citations). Katarı́na Rašlová has collaborated with scholars based in Slovakia, Czechia and United Kingdom. Frequent co-authors include Mária Dušinská, Andrew Collins, Helena Petrovská, Martina Somorovská, Nicholas J. Vaughan, Mihalis I. Panayiotidis, Susan J. Duthie, Michael Franklin, Branislav Vohnout and Itamar Raz. Their work appears in journals such as PLoS ONE, Free Radical Biology and Medicine and Food and Chemical Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact